Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
I'm so glad we gave the profit and shareholder driven model for our healthcare system. What a grand way to make sure funds go towards care!?
Oh... Timmy needs his whole rectum removed because Goldman Sachs execs needed more yachts? Sorry, Timmy, the free hand of the market works in mysterious ways. It's ok, the cure is available to them, because it's priced at 1 million per dose. Insurance won't cover it.
